High central blood pressure is a significant risk factor for cardiovascular complications, adversely impacting heart health and overall well-being. Effective management is essential, particularly for patients with heart failure or refractory angina. The Cardio MedBed, an innovative non-invasive therapy, has shown promise in reducing central blood pressure and enhancing circulatory efficiency, offering a groundbreaking solution for those with persistent heart conditions.
This article explores the clinical evidence supporting the Cardio MedBed's ability to reduce strain on the heart and improve cardiovascular parameters.

1. Reducing Central Blood Pressure and Myocardial Oxygen Demand (April 2015)
A randomized controlled trial published in Clinical and Experimental Pharmacology and Physiology in April 2015 examined the impact of Cardio MedBed therapy on central blood pressure and myocardial oxygen demand in patients with heart failure.
Key Findings:
Lower Central Blood Pressure: The therapy significantly reduced central blood pressure indices, indicating decreased strain on the heart and enhanced overall circulation.
Reduced Aortic Pulse Pressure and Wasted Left Ventricular Energy: These reductions suggest improved efficiency in the heart’s pumping mechanism, leading to better cardiovascular performance.
Decreased Myocardial Oxygen Demand: By lowering the oxygen requirements of the heart muscle, the therapy mitigates stress on the cardiovascular system, helping patients manage their condition more effectively.
The study concluded that Cardio MedBed therapy is a viable adjuvant treatment for heart failure, improving functional classification and reducing the heart's workload.
2. Improving Systolic Blood Pressure in Refractory Angina (December 2008)
Another study, published in American Heart Journal in December 2008, investigated the effects of Cardio MedBed therapy on systolic blood pressure in patients with refractory angina—a condition characterized by persistent chest pain despite standard treatments.
Key Findings:
Improved Systolic Blood Pressure: Cardio MedBed therapy effectively reduced systolic blood pressure, providing relief for patients with refractory angina.
Enhanced Circulatory Efficiency: Improved oxygen delivery to heart tissues alleviated symptoms of angina, enabling patients to experience a better quality of life.
This study underscores the role of Cardio MedBed in managing cardiovascular parameters, making it a valuable tool for patients who have not responded to conventional therapies.
A Non-Invasive Solution for Cardiovascular Health

The Cardio MedBed offers a transformative approach to reducing central and systolic blood pressure, alleviating symptoms, and improving heart function in patients with heart failure and refractory angina.
Its ability to lower myocardial oxygen demand and enhance circulatory efficiency positions it as a promising non-invasive therapy for individuals seeking effective cardiovascular care.
As research continues to validate its benefits, Cardio MedBed therapy stands out as a potential cornerstone in the management of persistent heart conditions. For more details, explore the studies linked above to learn more about this innovative therapy.
With the purchase of every Cardio MedBed comes the chance to participate in the New World Practitioner Certification FOR FREE! Go to DODPOWERPACK.COM for more information on these certifications.